SuperCrowd

Impact investing news for the SuperCrowd

Thu · Aug 13, 2026 Reg CF filings Sourced from SEC EDGAR
← All filings
Amendment · Form C/A

An amendment to an offering — the company changed its terms or corrected its filing.

20/20 GeneSystems, Inc.

2020gene.com · DE · Filed Nov 14, 2022

20/20 GeneSystems, Inc. filed a Form C/A — amendment — with the SEC on Nov 14, 2022. The Regulation Crowdfunding offering seeks $9,995, up to a maximum of $4,999,995 on StartEngine. Investors receive: Other. The offering closes 12-15-2022.

Target raise$9,995
Maximum raise$4,999,995
SecurityOther
Closes12-15-2022
PortalStartEngine
View the official filing on SEC EDGAR →

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.